ArticleMolecular cancer therapeutics2026

Development of a SIN1 Targeting Inhibitor as a Novel Therapeutic Approach for the Treatment of Malignancies.

Elspeth M Beauchamp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.